Medicine and Science from The BMJ
Health & Fitness:Medicine
Andrew Pollard is Director of the Oxford Vaccines Group - who, along with Astra Zeneca, have developed an modified adenovirus vaccine for SARS-CoV-2.
In this interview we talk to him about the development of that vaccine - what he thinks about the UK government's plan to increase the interval between doses; if he worries about a mutating virus and vaccine escape; and how the university came to make a deal with a commercial company to provide cost-price vaccinations for the world.
view more
www.bmj.com/coronavirus
More Episodes
Social prescribing
2019-04-04
2019-04-04
Applying new power in medicine
2019-04-01
2019-04-01
An acutely disturbed person in the community
2019-03-21
2019-03-21
#talkaboutcomplications
2019-03-14
2019-03-14
Ebola - Stepping up in Sierre Leone
2019-03-08
2019-03-08
Signals from the NIHR
2019-03-07
2019-03-07
Sorry for the interruption in service
2019-02-22
2019-02-22
Safeguarding LGBT+ young people
2019-02-15
2019-02-15
Should we be screening for AF?
2019-02-14
2019-02-14
Chronic Rhinosinusitis
2019-02-08
2019-02-08
Get this podcast on your
phone, FREE
